Literature DB >> 31493991

Infantile neuroaxonal dystrophy in a pair of Malaysian siblings with progressive cerebellar atrophy: Description of an expanded phenotype with novel PLA2G6 variants.

Limin Li1, Choong Yi Fong1, Chee Geap Tay1, Sok Kun Tae1, Hisato Suzuki2, Kenjiro Kosaki2, Meow-Keong Thong3.   

Abstract

Infantile neuroaxonal dystrophy 1 (INAD) (OMIM #256600) is a rare infantile onset neurodegenerative disease characterised by neuroregression and hypotonia, evolving into generalized spasticity, blindness and dementia. We report our diagnostic approach of a pair of siblings with psychomotor regression, hypotonia, optic atrophy and auditory neuropathy. The brain magnetic resonance imaging (MRI) showed progressive cerebellar atrophy. Genetic testing of the PLA2G6 confirmed presence of compound heterozygous novel mutations. As the variant c. 196C>T (p.Gln66X) was a truncating variant, it was considered as pathogenic while the variant c. 2249G>A (p. Cys750Tyr) was considered as "likely pathogenic" by bioinformatics analyses. Our patient expands the clinical phenotype of INAD as it described the first South-East Asian patient with INAD-associated auditory neuropathy. Our report highlights the importance of increased awareness of this condition amongst clinicians, the use of deep phenotyping using neuroimaging and the clinical utility of gene sequencing test in the delineation of syndromes associated with infantile neurodegenerative disease.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Auditory neuropathy; Cerebellar atrophy; Infantile neuroaxonal dystrophy; Novel mutation

Mesh:

Substances:

Year:  2019        PMID: 31493991     DOI: 10.1016/j.jocn.2019.08.111

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  1 in total

1.  Novel insertion mutation in the PLA2G6 gene in an Iranian family with infantile neuroaxonal dystrophy.

Authors:  Dorsa Rostampour; Mohammad Reza Zolfaghari; Milad Gholami
Journal:  J Clin Lab Anal       Date:  2022-01-29       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.